DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025

BROSSARD, Quebec, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announces that it intends to extend the exercise period of an aggregate of 3,502,931 stock warrants (each a “Warrant”) issued as part of a non-brokered private placement of units initially announced on June 5, 2024 and set to expire on December 5, 2025.

Read more at globenewswire.com